Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis.
about
Corticosteroids in acute respiratory failurePerioperative glucocorticoid administration for prevention of systemic organ failure in patients undergoing esophageal resection for esophageal carcinoma.Childhood asthma--office management.Systemic corticosteroid therapy for acute asthma exacerbations.Effects of inhaled fluticasone and oral prednisolone on clinical and inflammatory parameters in patients with asthma.Prolonged glucocorticoid treatment is associated with improved ARDS outcomes: analysis of individual patients' data from four randomized trials and trial-level meta-analysis of the updated literature.Hydrocortisone treatment in early sepsis-associated acute respiratory distress syndrome: results of a randomized controlled trial.A review of associated controversies surrounding glucocorticoid use in veterinary emergency and critical care.Efficacy of methylprednisolone in children with severe community acquired pneumonia.The role of corticosteroids in respiratory diseases of children.Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development.Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (Part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017.Immunosuppressant pharmacodynamics on lymphocytes from healthy subjects and patients with chronic renal failure, nephrosis, and psoriasis: possible implications for individual therapeutic efficacy.Prolonged low-dose methylprednisolone treatment is highly effective in reducing duration of mechanical ventilation and mortality in patients with ARDS
P2860
Q28145486-BEE536A4-02B0-4D9C-A7C6-27510BA83A9EQ33252289-169FBA14-8A02-4C70-B8F4-BD7D58DB85D3Q33929165-CF2FE8FE-E989-4B2D-B6E3-FACA6D650697Q34541967-73F266ED-20B7-4C86-89D6-E938EBEFB3B3Q35532821-FE9BA507-E432-49DD-87DB-CBFDE2B3B2B2Q35823842-41974C57-7ACC-43E3-BE31-1B8310AEBCE1Q38386593-AE114E84-0E29-49A6-895F-A87E1AC77A4DQ38816542-C5DCA2DF-CC4D-46B2-8AD0-84BDFC94E457Q40286913-7A377149-68C9-4CD1-A720-AF334B5A15CAQ41151318-54D754BA-1A15-455F-A2C9-9924BC40B557Q46438856-B7B9B5A2-1E04-451A-A4E0-16B75807E673Q46522413-8891F89B-2DCE-4A1A-9A18-AD679352F166Q54149991-C145D391-2B84-4D35-9BC9-1FD495465127Q58707340-8F8DBDB1-F79D-46EC-9BC1-496F31A43B46
P2860
Methylprednisolone achieves greater concentrations in the lung than prednisolone. A pharmacokinetic analysis.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Methylprednisolone achieves gr ...... e. A pharmacokinetic analysis.
@en
type
label
Methylprednisolone achieves gr ...... e. A pharmacokinetic analysis.
@en
prefLabel
Methylprednisolone achieves gr ...... e. A pharmacokinetic analysis.
@en
P2093
P356
P1476
Methylprednisolone achieves gr ...... e. A pharmacokinetic analysis.
@en
P2093
Bloedow DC
Szefler SJ
Vichyanond P
P304
P356
10.1164/AJRCCM/144.3_PT_1.586
P433
P577
1991-09-01T00:00:00Z